•
Mar 31, 2024

iTeos Therapeutics Q1 2024 Earnings Report

Total Revenue
$0
Previous year: $12.6M
-100.0%
EPS
-$1.07
Previous year: -$0.44
+143.2%
Gross Profit
-$303K
Previous year: $12.4M
-102.4%
Cash and Equivalents
$449M
Previous year: $225M
+99.3%
Free Cash Flow
-$33.3M
Previous year: -$26.7M
+25.0%
Total Assets
$630M
Previous year: $728M
-13.5%

iTeos Therapeutics

iTeos Therapeutics